UK approves Pfizer-BioNTech 1:23 vaccine
(CNN) -
BioNTech CEO Ugur Sahin spoke to CNN and said that a very important milestone had been reached: people outside of clinical trials would soon have access to the vaccine in the UK, “and we think it really is. the beginning of the end of the pandemic.
"Of course it is the first country to enable an authorization and probably others will follow, but it is a good start," Sahin said on CNN's New Day program.
The 5 keys you should know about the Pfizer / BioNTech vaccine against coronavirus
Everything you need to know about the Pfizer and BioNTech vaccine 3:25
He said the first people would get the first vaccine early next week.
Regarding the United States, Sahin said BioNTech / Pfizer are in close contact with the FDA, answering their questions, and have a business meeting scheduled for December 10.
"And after the evaluation meeting, depending on the outcome of the meeting, it could be very fast, so it could happen the days after the evaluation meeting, we could obtain authorization, and if we obtain authorization we can start the administration of the vaccine very fast.
advertising
When can you get vaccinated?
This is all you need to know about the Pfizer and BioNTech vaccine
Sahin said the company was set to deliver up to 50 million doses to different regions in 2020, with a significant proportion of that going to the United States.
"Technically, we are prepared to start implementation, of course, it depends on regulatory approval," said BioNTech CEO.
BioNTechCoronavirus Vaccine
